Harold Edward Fleming - Net Worth and Insider Trading
Harold Edward Fleming Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harold Edward Fleming owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Harold Edward Fleming’s form 4 insider trades.
Insider Ownership Summary of Harold Edward Fleming
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CRSP | CRISPR Therapeutics AG | 2021-06-10 | director |
Harold Edward Fleming Trading Performance
Harold Edward Fleming Ownership Network
Harold Edward Fleming Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Harold Edward Fleming is the director of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Harold Edward Fleming made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 225,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 0 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,087 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,087 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Harold Edward Fleming Mailing Address
Above is the net worth, insider trading, and ownership report for Harold Edward Fleming. You might contact Harold Edward Fleming via mailing address: C/o Crispr Therapeutics Ag, 610 Main Street, Cambridge Ma 02139.